T
Tidal Therapeutics
Cambridge, United States
Founded 2021
Nanomedicine Lipid Nanoparticles Gene Therapy Delivery Drug Delivery Cell Therapy Nano mRNA Delivery
About
LNP-based in vivo gene therapy for immune cells, acquired by Sanofi
Company Details
- Type
- commercial
- Employees
- 50-100
- Funding
- Acquired by Sanofi
Key Products
- In Vivo LNP Platform